Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Massive Reversal in Precious Metals but Fundamentals Improving

To underscore the volatility of this past week, consider the price action in Silver. Silver, days ago, had a chance to make its highest monthly close since October 2016. That is well over three years ago. Silver closed the week and the month at its lowest levels in six mon...
Jordan Roy-Byrne, CMT | March 2, 2020 |

Revolutionizing Mental Health Treatment

(Click to play video.) Cybin Inc. ( NEO: CYBN , NYSE: CYBN , Forum ) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and...
Featured Submission | August 13, 2021 |

Will U.S. Shale Survive If Oil Hits $40?

Within a month, the U.S. oil benchmark West Texas Intermediate recorded two first-of-a-kind events. First, it fell below zero on April 20. Then, it soared up so high it is about to book its best month ever, CNBC's Pippa Stevens noted in a recent commentary. Still, many ...
Irina Slav | May 28, 2020 |

Buzz on the Bullboards: Today’s gainers and tomorrow’s winners

Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...
Jonathon Brown | May 4, 2023 |

This Signal Points To More Upside In Stocks

NEW MONTHLY SIGNALS The MSCI World Index tracks over one thousand large and mid-cap stocks in twenty-two developed countries, covering 85% of the market capitalization in those regions. As shown via the chart below, a positive monthly MACD cross was just nailed down on the...
Chris Ciovacco | December 3, 2019 |

The Company Creating a Real Buzz in the Exploding Agri-Tech Marketplace

A radical technology that’s part of the New Green Revolution. Multiple patents. Regulatory environment approval. An experienced and forward-thinking management team. These are the things that make investors drool. Enter Bee Vectoring Technology (BVT) ( ...
Dave Jackson | February 27, 2020 |

Tandem Increases Unit Sales of t:slim X2 Insulin Pumps 290% Worldwide

Tandem Diabetes Care's second quarter earnings highlighted a 290% increase in unit sales of its t:slim X2 insulin pumps that feature integrated continuous glucose monitoring and remote software update capability. Insulin delivery and diabetes medical device mak...
Streetwise Reports | August 6, 2019 |

Best Canadian Stocks

When it comes to investing in Canadian companies, bigger is not always better. Canada’s historic corporate giants – energy and material sectors, such as the forestry industry – have had a difficult time over the past few years due to macroeconomic condition...
Stockhouse Editorial | June 4, 2019 |

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...
Streetwise Reports | September 27, 2019 |

4th of July Fireworks in the S&P 500

The only time the bears appeared during yesterday's trading, was at the very U.S. open. A steady move higher followed, with the final hourly upswing erased 15 minutes before the closing bell. How concerning is this? I don't think it's a setback worth much mentioning. Yeste...
Monica Kingsley | July 2, 2020 |
1 2 3 4 5 6 7 8 9 10 ...